Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Drug Topics Community Pharmacists' Report

Drug Topics
Community
Pharmacists' Report

DrugTopics.com

October 24, 2011

MEDICATION SAFETY

Senate defeats personal importation bill

The NACDS lauded the U.S. Senate’s vote last week to defeat an amendment that would have allowed “personal importation” of prescription medications from Canada. » More

COMMUNITY PHARMACY

PCPAN coalition opposes ESI/Medco merger

The opposition to the proposed Express Scripts and Medco Health Solutions merger got stronger last week with the formation of a national coalition. » More

Walgreens, Novo Nordisk promote free needle collection and disposal system program

Walgreens and Novo Nordisk have teamed up to offer the Sharps’ Complete Needle Collection & Disposal System for free during a special promotional program to customers who require injectable medications. » More

Bartell gives Seattle store a “next generation” makeover

Seattle, Wash.-based Bartell Drugs, a chain of 58 stores, recently unveiled its “next generation” store. » More

Survey

If two of the nation's largest PBMs, Express Scripts and Medco, merge, what would be the most significant implication for the industry?

a) Enhanced competition within the industry, resulting in even lower drug costs for PBM payer clients
b) Express Scripts' size advantage could reduce competition and increase long-term costs for payers
c) Increased pressures on retail pharmacies to compete in the market
d) Increased quality of PBM services across the industry as other PBMs strive to stay competitive
e) Minimal, if any

Respond here and see what your colleagues think too.

Want to see the results of our last survey about whether your pharmacy imposes a daily quota of filled prescriptions? Click here.

FDA ACTIONS

Vivus resubmits NDA for Qnexa

Vivus has resubmitted its NDA for Qnexa (phentermine/topiramate) to FDA. » More

TECHNOLOGY

Diabetes Navigator showcases type 2 diabetes resources online

The AACE and Takeda Pharmaceuticals North America Inc. have partnered to launch the Diabetes Navigator. » More

 
Twitter  

Follow us on Twitter

Voices

DT Blog

JP at Large

View from the Zoo

Viewpoints

Regulatory & Legal

 

Meetings & Events

Digital Edition

View current edition

Cover
 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.